Search Results - sudath+hapuarachchige

1 Results Sort By:
Targeted Nano-Delivery of Aurora Kinase Inhibitors for Cancer Therapy
Value Proposition·      Kinase inhibition is a highly effective, targeted therapy that is standard of care for many cancers.·      Aurora kinase inhibition is a promising class of these therapeutics demonstrated to successfully inhibit tumor growth and promote patient survival in various cancer indications. However, current oral administration requires...
Published: 7/24/2026   |   Inventor(s): Sudath Hapuarachchige
Keywords(s):  
Category(s): Clinical and Disease Specializations > Oncology, Technology Classifications, Technology Classifications > Therapeutic Modalities > Repurposed Drugs
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum